DOI: https://doi.org/10.22141/2224-0721.7.63.2014.77128

Screening for Type 2 Diabetes Mellitus by Determination of Glycated Hаemoglobin

L.O. Prystupiuk

Abstract


Objective — to identify the prevalence of disorders of carbohydrate metabolism according to the results of for glycated hemoglobin screening.
Materials and Methods. The determination of glycated hemoglobin (HbA1c) in 1564 people aged 18 to 90 years has been carried out. The age structure of the surveyed was as follows: up to 45 years — 20 % of the total number surveyed; 46–59 years — 38 %; 60–74 — 30 %; 75 years and over — 12 %. Laboratory studies were performed in the laboratory centers Synevo. Evaluation of the findings was carried out by the level of HbA1c in venous blood: up to 6 % — disorders of carbohydrate metabolism does not exist; 6.1–6.4 % — prediabetes; more than 6.5 % — diabetes mellitus.
Results. In 62 % of the total number of surveyed, HbA1c levels did not exceed 6 %. In 12 % HbA1c level was within 6.1–6.4 %. In 16 % of patients revealed HbA1c level was 6.5 % or more. These individuals may be patients with diabetes mellitus type 2. They require further detailed examination and therapy in accordance with the current protocol in Ukraine regarding treatment of patients with diabetes mellitus type 2.
Conclusions. Screening for content of glycated hemoglobin revealed violations of carbohydrate metabolism, which in 12 % of the total surveyed can be regarded as a state of prediabetes, in 16 % — as type 2 diabetes mellitus. The number of patients diagnosed with type 2 diabetes mellitus is increasing after the age of 46 years, reaching a maximum in men of age group 60–74 years, in women — after 75 years. The low interest of the population in screening for the state of carbohydrate metabolism draws attention. Only 25 % of invited subjects have carried out a survey.


Keywords


type 2 diabetes mellitus; prediabetes; glycated haemoglobin; screening

References


Довідник основних показників діяльності ендокринологічної служби України за 2013 рік / А.Д. Чернобров, М.Д. Тронько. — К., 2014. — 40 с.

Сергиенко В.И., Бондарева И.Б. Математическая статистика в клинических исследованиях. — М.: ГЭОТАР-Медицина, 2000. — 256 с.

Халангот М.Д., Кравченко В.І., Писаренко Ю.М. та ін. Дослідження поширеності цукрового діабету, порушеної толерантності до глюкози та антропометричні фактори ризику їх розвитку в мешканців літнього віку сільської місцевості України // Ендокринологія. — 2014. — Т. 19, № 2. — С. 119-125.

Паньків В.І. Нові терапевтичні можливості управління цукровим діабетом 2-го типу: досвід використання воглібозу // Міжнародний ендокринологічний журнал. — 2014. — № 6(62). — С. 51-54.

Chamnan P., Simmons R.K., Khaw K.T. et al. Change in HbA1 cover 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single timepoint // Diabetologia. — 2013. — 56. — 1004-1011. doi 10.1007/s00125-013-2854-8

Hu Y., Liu W., Chen Y. еt al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance // Acta Diabetologica. — 2010. — Vol. 47. — P. 231-236.

Kurukulasuriya L.R., Sowers J.R. Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors // Cardiovascular Diabetology. — 2010. — Vol. 9. — 45. doi:10.1186/1475-2840-9-45

Lauritzen T., Sandbaek A., Skriver M.V., Borch-Johnsen K. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark // Diabetologia. — 2011. — Vol. 54. — P. 1318-1326. doi 10.1007/s00125-011-2077-9

Mankovsky B. The prevalence of undiagnosed type 2 diabetes mellitus in Ukraine // Diabetologia. — 2007. — Vol. 50. — Suppl. 1. — P. 376.

Naka K., Papathanassiou K., Bechlioulis A. et al. Determinants of vascular function in patients with type 2 diabetes // Cardiovascular Diabetology. — 2012. — Vol. 11. — 127. doi:10.1186/1475-2840-11-127

Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. — World Health Organization, 2011. — 40 р.

Zimmet P.Z., Magliano D.J., Herman W.H., Shaw J.E. Diabetes: a 21st century challenge // Lancet. Diabetes and Endocrinology. — 2013. — P. 5-13.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта